{"organizations": [], "uuid": "015ba0b855981937ecec40761b94d81ad89a052f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/3", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/05/22/globe-newswire-ravenquest-provides-corporate-update.html", "country": "US", "domain_rank": 767, "title": "RavenQuest Provides Corporate Update", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.05, "site_type": "news", "published": "2018-05-22T14:00:00.000+03:00", "replies_count": 0, "uuid": "015ba0b855981937ecec40761b94d81ad89a052f"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/05/22/globe-newswire-ravenquest-provides-corporate-update.html", "ord_in_thread": 0, "title": "RavenQuest Provides Corporate Update", "locations": [], "entities": {"persons": [{"name": "lisa macneil", "sentiment": "none"}, {"name": "lisa", "sentiment": "none"}], "locations": [{"name": "vancouver", "sentiment": "none"}, {"name": "british columbia", "sentiment": "none"}, {"name": "frankfurt", "sentiment": "none"}, {"name": "markham", "sentiment": "none"}, {"name": "innomar strategies", "sentiment": "none"}, {"name": "maricann", "sentiment": "none"}, {"name": "ontario", "sentiment": "none"}], "organizations": [{"name": "ravenquest biomed inc.", "sentiment": "negative"}, {"name": "shoppers drug mart", "sentiment": "none"}, {"name": "mcneil consumer health care", "sentiment": "none"}, {"name": "maricann group inc.", "sentiment": "none"}, {"name": "lifescan canada ltd.", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "VANCOUVER, British Columbia, May 22, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) (OTCQB:RVVQF) (Frankfurt:1IT) is pleased to announce the appointment of Lisa MacNeil as Operations Lead at the Company’s Bloomera facility located in Markham, Ontario.\nLisa was previously the Client Services Manager at Maricann Group Inc., a licensed producer in Ontario. At Maricann, she led client relations and sales operations, and managed various business development projects for the company while ensuring compliance with regulatory and corporate requirements.\nLisa was also the Senior Program Manager, Innomar Strategies where she provided strategic insights and support for program services, performed regular assessment of program efficiencies for continuous system improvement and created and updated Standard Operating Procedures, work orders and proposals. She has extensive experience in the health care sector by working with Shoppers Drug Mart, Lifescan Canada Ltd. and McNeil Consumer Health Care.\n“We are excited to have Lisa recognize the unique opportunity within the RavenQuest team as our bench strength continues to grow,” stated CEO, George Robinson. “Lisa will provide overall direction to teams within Bloomera in charge of Facility, Quality Assurance and Plant Health. Her knowledge of the ACMPR and operational experience in the regulated cannabis industry will be a significant contribution to Bloomera as RavenQuest prepares for sales and ramped up production.”\nAbout RavenQuest BioMed Inc.\nRavenQuest BioMed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development.\nOn Behalf of the Board of Directors of\nRAVENQUEST BIOMED INC.\n“George Robinson”\nChief Executive Officer\nFor further information, please contact:\nMathieu McDonald, Corporate Communications – 604-484-1230\nNeither Canadian Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Stock Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.\nCautionary Note Regarding Forward-Looking Statements\nAll statements in this press release, other than statements of historical fact, are \"forward-looking information\" with respect to the Company within the meaning of applicable securities laws, including statements with respect to the development of a licensed cannabis production facility and anticipated production from such a facility. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited to those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com . Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.\nSource:RavenQuest BioMed Inc.", "external_links": ["https://www.globenewswire.com/Tracker?data=GTiAGi4sY1TwILMV1vhwwK3CAlbtvLLmECx0iQOiot6cgWNqRx5rLz9XwiGM-RglIpRdXPbnVIPHdsZoPSnBlA==", "https://www.globenewswire.com/NewsRoom/AttachmentNg/ae0da4c9-726b-4ae7-818e-6cfaac910417"], "published": "2018-05-22T14:00:00.000+03:00", "crawled": "2018-05-22T15:48:13.000+03:00", "highlightTitle": ""}